The world’s largest vaccine producer Serum Institute of India (SII) is about to sign a corona vaccine-coveyshield supply contract with the central government. Accordingly, a dose will be given to the government for 250 rupees.
The Serum Institute of India (SII) has sought emergency approval for CoveShield in India and government sources have indicated that a decision may be taken soon. The process of emergency approval has already been expedited. If everything goes well, the vaccination will start in the country from January. Coveshield is developed by Oxford University and AstraZeneca. Serum Institute in India has done its phase-2/3 trials.
SII Chief Executive Officer Adar Poonawala had earlier also said that a dose of the vaccine would be available in the private market in India for Rs 1,000. A large scale supply deal with the government will be at a low cost. It was being said from the beginning that this vaccine would be made available to the government for 3 dollars, ie, Rs 225 to Rs 250. Poonawala also said that his first focus is on supplying vaccines in India.
